Literature DB >> 15198305

Captopril and enalapril improve cognition and depressed mood in hypertensive patients.

Jan J Braszko1, Wiesława Karwowska-Polecka, Dorota Halicka, Paul R Gard.   

Abstract

UNLABELLED: In this study, we evaluate the effects of two angiotensin converting enzyme inhibitors (ACEIs), captopril and enalapril given chronically as antihypertensive treatment, on certain cognitive and emotional processes in humans. Thirty-nine subjects with mild to moderate hypertension and fifteen normotensive controls were divided into four groups consisting of normotensive and hypertensive subjects taking captopril, enalapril, or no medication at all. The Rey Auditory Verbal Learning Test and the Wechsler Memory Scale were used to evaluate their cognitive functioning. Mood changes in all subjects were assessed using the Beck Depression Inventory and the Hopkins Symptom Check- list (HSC).
RESULTS: Untreated hypertensive patients scored lower than normotensive controls in cognitive tests and significantly worse in cumulative recall (P < 0.05) and paired words association (P < 0.01). When compared with normotensive subjects, untreated hypertensive patients also scored significantly higher on the depression with anxiety subscale in HSC (P < 0.05). No significant influence of hypertension was found in any other examined aspect of cognition and mood. In most cases captopril improved and enalapril reversed the adverse memory effects of hypertension. High arterial blood pressure is significantly associated with an impairment of cognition and the occurrence of depression with anxiety in humans. Enalapril and, to a lesser extent, captopril reversed these deficits.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15198305     DOI: 10.1515/jbcpp.2003.14.4.323

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  25 in total

Review 1.  Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2011-09-22       Impact factor: 5.046

Review 2.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 3.  Hypertension in postmenopausal women.

Authors:  Roberta Lima; Marion Wofford; Jane F Reckelhoff
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 4.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

5.  Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy.

Authors:  Jana D Tchekalarova; Natasha Ivanova; Dimitrina Atanasova; Daniela M Pechlivanova; Nikolai Lazarov; Lidia Kortenska; Rumiana Mitreva; Valentin Lozanov; Alexander Stoynev
Journal:  Cell Mol Neurobiol       Date:  2015-10-13       Impact factor: 5.046

Review 6.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

7.  Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice.

Authors:  Lei Wang; Helmut Hiller; Justin A Smith; Annette D de Kloet; Eric G Krause
Journal:  Physiol Genomics       Date:  2016-07-28       Impact factor: 3.107

8.  Relationship between depression and specific health indicators among hypertensive African American parents and grandparents.

Authors:  Jacquelyn Y Taylor; Olivia G M Washington; Nancy T Artinian; Peter Lichtenberg
Journal:  Prog Cardiovasc Nurs       Date:  2008

Review 9.  Cognitive-enhancing effects of angiotensin IV.

Authors:  Paul R Gard
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

10.  The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition.

Authors:  Ihab Hajjar; Meaghan Hart; William Milberg; Vera Novak; Lewis Lipsitz
Journal:  BMC Geriatr       Date:  2009-11-18       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.